Antiepileptic Medication-induced Severe Cutaneous Adverse Reactions in Hospitalized Children: A Retrospective Study

Bahareh Abtahi-Naeini1, Reza Makhmali2, Niloufar Amini3

  • 1Division of Pediatric Dermatology, Department of Pediatrics, Imam Hossein Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran AND Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. abtahi.baharah@yahoo.com.

Insights

Severe cutaneous adverse reactions (SCARs) in children are linked to antiepileptic drugs. Phenobarbital was the most common cause, with hypersensitivity syndrome being most frequent. Risk factors like lymphadenopathy and sex influenced specific SCAR types.

Area of Science:

  • Pediatric Pharmacology
  • Dermatology
  • Clinical Toxicology

Background:

  • Limited data exists on severe cutaneous adverse reactions (SCARs) from antiepileptic drugs in children.
  • Antiepileptic medications are frequently prescribed, necessitating understanding of their adverse effects.

Purpose of the Study:

  • To investigate the clinical and epidemiological characteristics of antiepileptic medication-induced SCARs in hospitalized children.
  • To identify common antiepileptic drugs causing SCARs and associated risk factors.

Main Methods:

  • A five-year retrospective study at Isfahan University of Medical Sciences, Iran.
  • Included children with SCARs (hypersensitivity syndrome, DRESS, SJS/TEN) due to antiepileptic drugs.
  • Data analyzed using multinomial logistic regression.

Main Results:

  • Phenobarbital was the most frequent antiepileptic drug implicated in SCARs.
  • Hypersensitivity syndrome (76.83%) was more common than DRESS (16.22%) and SJS/TEN (6.95%).
  • Lymphadenopathy increased DRESS risk 35-fold; girls had 6x higher SJS/TEN risk. Age, weight, and mucosal involvement impacted hospitalization.

Conclusions:

  • Clinical and epidemiological features of antiepileptic drug-induced SCARs in Iranian children show variations.
  • Understanding these characteristics is crucial for early diagnosis and management of SCARs in pediatric populations.
Abstract

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
371
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
320
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
511
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
171
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385